Caregivers, 91

Categories of recommended HIV disability allowances in report, xxii

HIV-associated conditions without Listings in other body systems, xi

HIV-associated diseases with existing Listings elsewhere, xixii

imminently fatal conditions, xi

low CD4 count, xxi

CD4 cell count, 34, 4749, 113, 129

indicating disease progression, 4550

as an indicator of disability, xxi, 67, 4552

progression of untreated HIV infection demonstrated by, 46

Centers for Disease Control and Prevention (CDC), x, 1, 15, 29, 33, 47, 82, 96, 105

Central nervous system (CNS), lymphomas arising within, 56, 82, 148

Cervical cancer, invasive, 82

Children, defining, 2n

Children with HIV/AIDS

concepts specific to, x, 1012, 8799, 131132

mood disorders, with HIV, 91

proposed disabling CD4 count ranges for children, 11

rationale for listing recommendations for pediatric patients, 9296

specialized evaluation of cases involving, 21

survival and prognosis, 8892

Children with HIV Early Antiretroviral Therapy trial, 90

Chronic conditions

associated with aging, 15

HIV infection as, ix, 33, 101

Chronic diarrhea, defining, 66

Chronic hepatitis, 81

Chronic inflammatory state, associated with HIV infection, 33, 78

Chronic kidney disease

including HIV-associated nephropathy, 7980

an increasing problem for the HIV-infected, xi

Chronic pancreatitis, 147148

Cirrhosis of the liver, 81

Collagen-vascular diseases, 81

Combined antiretroviral therapy. See Antiretroviral therapy

Committee on Social Security HIV Disability Criteria, 12, 2931

charge to, 12, 16, 141155

considerations for developing a Listing, 30

methods, 2930

scope of the report, 3031

Comorbidities of HIV, 9, 3435

anxiety, 28, 35, 91

behavioral disorders, 35

bipolar disorder, 28, 35

cognitive dysfunction, 35

cognitive limitations, 34-35, 103

delirium, 35

drug dependence, 35

in the Listings, 8384

major depressive disorder, 34

posttraumatic stress disorder, 35

psychiatric disorders, 35

schizophrenia, 28, 35

substance abuse, 34

Composite International Diagnostic Interview, 28

Concurrent conditions, 63

Conditions covered elsewhere in the Listings, 10, 7784

cardiovascular disease, 10, 7879, 84

chronic kidney disease, including HIV-associated nephropathy, 10, 7980, 84

diabetes, 10, 8081, 84

hepatitis, 10, 8182, 84

list of, 10, 78, 84

malignancies not otherwise specified, 10, 8284

Conditions currently without Listings, 9, 6474

diarrhea, 9, 6466, 73

distal sensory polyneuropathy, 9, 64, 6667, 74

HIV-associated neurocognitive disorders (HAND), 9, 64, 6769, 74

HIV-associated wasting syndrome, 9, 64, 6970, 74, 123

Kaposi’s sarcoma, 9, 64, 7071, 74

lipoatrophy and lipohypertrophy, 9, 64, 7172, 74

osteoporosis, 9, 64, 7274

Contrast-enhanced computed tomography (CT), 56, 72

“Controlling weight,” applied to treating source opinions, 22

Cross-referencing procedure in the SSA, 77, 8384

Curcumin, 66

Current concepts in HIV/AIDS, 3343

evolution of the epidemic, 3336

improvements in functioning and capacity to return to work, 3941

management of HIV/AIDS, 3639



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement